MYPROSTATESCORE 2.0
Clear Results. Confident Decision.
MPS2 is a urine test designed to predict the presence of clinically significant prostate cancer by analyzing a comprehensive array of 18 unique gene transcripts. Our algorithm has been developed to optimize diagnostic accuracy and provide clinical flexibility, allowing MPS2 to be run as a biomarker-only test or inclusive of clinical risk factors, depending on provider preference. Receive individualized reports with results tailored to unique patient and clinical context.
Stay Up To Date
Resources
Industry news, men’s health information, and expert prostate cancer and risk assessment research.
5 Common Questions About Prostate Cancer, Answered
Information regarding prostate cancer symptoms, treatment options and their side effects, prognosis and survival rate, and how to detect it early.
What is a Prostatectomy, and What Does it Mean for Men Who Have Them?
Learn about open and laparoscopic prostatectomies performed to treat prostate cancer, the risks and what to expect after surgery.
Understanding Your MPS2 Patient Risk Report
Learn how to best understand your MyProstateScore 2.0 (MPS2) test results and work with your doctor to determine your next steps.